Related Experiment Videos
Cholelithiasis and urolithiasis in Crohn's disease
Scandinavian Journal of Gastroenterology
|March 1, 1987
Summary
Patients with Crohn's disease affecting the distal ileum have a higher risk of developing gallstones and kidney stones, especially after extensive small bowel resection. Metabolic issues like steatorrhea contribute to this increased stone formation.
Area of Science:
- Gastroenterology
- Nephrology
- Metabolic Medicine
Background:
- Crohn's disease frequently involves the distal ileum, impacting nutrient absorption.
- Ileal resection can lead to malabsorption syndromes, including steatorrhea and bile salt malabsorption.
- These metabolic disturbances are implicated in the formation of gallstones and renal stones.
Purpose of the Study:
- To investigate the incidence of gallstones and renal stones in patients undergoing surgery for distal ileum Crohn's disease.
- To determine the correlation between the extent of small bowel resection and the prevalence of gallstone and renal stone disease.
- To explore the long-term probability of stone formation in patients with distal ileopathy.
Main Methods:
- Retrospective analysis of 107 patients with Crohn's disease involving the distal ileum.
- Categorization of patients based on the extent of diseased or resected small bowel (minor vs. >100 cm).
- Calculation of stone formation probability over time.
Main Results:
- Overall incidence of gallstones was 17% and renal stones was 12%.
- Patients with >100 cm small bowel resection had a 35% incidence of gallstones compared to 9% with minor resections.
- Renal stone incidence was 28% in patients with >100 cm resection (excluding colectomized patients), significantly higher than controls.
Conclusions:
- Resection of the distal ileum in Crohn's disease significantly increases the risk of both gallstone and renal stone formation.
- The extent of small bowel resection is directly correlated with the likelihood of developing these stones.
- Metabolic disturbances arising from bile salt and fat malabsorption are the primary drivers of increased stone disease.